Used in biochemical research to investigate the properties of compounds with a benzylisoquinoline structure, which exhibit effects on the central nervous system, particularly through inhibition of the enzyme acetylcholinesterase. It holds potential as a lead compound for developing treatments for neurological disorders, such as Alzheimer's disease. Additionally, it is studied for its antimicrobial, anti-inflammatory, and antioxidant activities, including modulation of cellular pathways related to oxidative stress. Primarily employed in laboratory settings for pharmacological, biochemical, and therapeutic agent development studies.